Sang Joon Lee (SangJoon Lee)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Venues

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

British journal of clinical pharmacology

Blood advances

Cancer chemotherapy and pharmacology

Celltrion Inc

Texas A&M University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Celltrion Inc

South Korea

Vice President :: Clinical Development

Education History

Texas A&M University

United States

PHD :: Statistics

Publications

Justin Stebbing, Yauheni Baranau, Valery Baryash, Vladimir Moiseyenko, Dmytro Boliukh, Nicoleta Antone, Alexey Manikhas, Anatolii Chornobai, Tae Hong Park, Eric Hyungseok Baek, Jaeyong Lee, Jiin Choi, Nahyun Kim, Keum Young Ahn, Sang Joon Lee, Sunghyun Kim
Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 Randomised Controlled Trial. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2023)
Sang Joon Lee, KyungMin Baek, Sujin Lee, Yoon Jee Lee, Jeong Eun Park, Seul Gi Lee
Post-Marketing Pooled Safety Analysis for CT-P13 Treatment of Patients with Immune-Mediated Inflammatory Diseases in Observational Cohort Studies. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 34 (4) (2021)
Antonia Davidson, Darin Brimhall, Jonathan Kay, Edward Keystone, Sang Joon Lee, Sung Hyun Kim, Yun Ju Bae, Eun Jin Choi, Daniel E Furst
Randomised, phase I pharmacokinetic study of adalimumab biosimilar CT-P17 (40 mg/0.4 mL) by autoinjector and prefilled syringe in healthy subjects. British journal of clinical pharmacology 87 (11) (2021)
Christian Buske, Wojciech Jurczak, Juan-Manuel Sancho, Edvard Zhavrid, Jin Seok Kim, Jose-Ángel Hernández-Rivas, Aliaksandr Prokharau, Mariana Vasilica, Rajnish Nagarkar, Larry Kwak, Won-Seog Kim, Sang Joon Lee, SungHyun Kim, KeumYoung Ahn, Michinori Ogura
Long-term efficacy and safety of CT-P10 or rituximab in untreated advanced follicular lymphoma: a randomized phase 3 study. Blood advances 5 (17) (2021)
Justin Stebbing, Yauheni V Baranau, Valery Baryash, Alexey Manikhas, Vladimir Moiseyenko, Giorgi Dzagnidze, Edvard Zhavrid, Dmytro Boliukh, Joanna Pikiel, Alexandru E Eniu, Rubi K Li, Beatrice Tiangco, Sang Joon Lee, Sunghyun Kim
Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer: final results from a randomized phase III trial. Breast cancer research and treatment 188 (3) (2021)
Francisco J Esteva, Justin Stebbing, Rebecca N Wood-Horrall, Peter J Winkle, Sung Young Lee, Sang Joon Lee
A randomised trial comparing the pharmacokinetics and safety of the biosimilar CT-P6 with reference trastuzumab. Cancer chemotherapy and pharmacology 81 (3) (2018)

Sang Joon Lee.css-eqlu8i{font-size:small;padding-left:4px;} (SangJoon Lee)

Publication Activity (10 Years)

Top Topics

Top Venues

Sang Joon Lee (SangJoon Lee)